Seres Therapeutics (MCRB) Ownership - Who Owns Seres Therapeutics?

1,084 Followers

Seres Therapeutics (MCRB) Ownership Overview

1.07% Insiders

4.22% Mutual Funds

13.17% Other Institutional Investors

4.33% ETFs

77.22% Public Companies and

Individual Investors

The ownership structure of Seres Therapeutics (MCRB) stock is a mix of institutional, retail, and individual investors. Approximately 21.71% of the company’s stock is owned by Institutional Investors, 1.07% is owned by Insiders, and 77.22% is owned by Public Companies and Individual Investors.

The ownership structure of Seres Therapeutics (MCRB) stock is a mix of institutional, retail, and individual investors. Approximately 17.39% of the company’s stock is owned by Institutional Investors, 1.07% is owned by Insiders, and 4.33% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Noubar Afeyan	1,155,850	Institution	12.00%	8,796,019
	276,116	Institution	2.87%	2,101,243
	276,116	Institution	2.87%	2,101,243
	63,492	Insider	0.66%	483,174
	58,550	Institution	0.61%	445,566
	55,940	Institution	0.58%	425,703
	33,558	Institution	0.35%	255,376
	31,577	Institution	0.33%	240,301
	16,749	Institution	0.17%	127,460
	14,538	Institution	0.15%	110,634

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
276,116	Institution	2.87%	2,101,243
58,550	Institution	0.61%	445,566
33,558	Institution	0.35%	255,376
11,153	Institution	0.12%	84,874
8,400	Institution	0.09%	63,924
7,500	Institution	0.08%	57,075
3,498	Institution	0.04%	26,620
2,982	Institution	0.03%	22,693
2,532	Institution	0.03%	19,269
1,176	Institution	0.01%	8,949

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	206,170	Institution	2.14%	1,828,728
Vanguard Extended Market ETF	69,946	Institution	0.73%	620,421
Avantis U.S. Small Cap Value ETF	49,641	Institution	0.52%	365,854
Schwab U.S. Small-Cap ETF	31,577	Institution	0.33%	232,722
Black Diamond Distressed Opportunities Fund Trust Units	22,472	Institution	0.23%	172,203
iShares Micro-Cap ETF	16,859	Institution	0.18%	124,251
Invesco FTSE RAFI US 1500 Small-Mid ETF	14,538	Institution	0.15%	110,634
WisdomTree U.S. SmallCap Fund	7,157	Institution	0.07%	54,465
Avantis U.S Small Cap Equity ETF	5,277	Institution	0.05%	38,891
Avantis U.S. Equity ETF	1,022	Institution	0.01%	7,532

FAQ

Who Owns Seres Therapeutics (MCRB)?

According to the latest TipRanks data, approximately 13.17% of the company's stock is held by institutional investors, 1.07% is held by insiders, and 77.22% is held by retail investors.

What percentage of Seres Therapeutics (MCRB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 13.17% of Seres Therapeutics (MCRB) stock is held by institutional investors.

What percentage of Seres Therapeutics (MCRB) stock is held by retail investors?

According to the latest TipRanks data, approximately 77.22% of Seres Therapeutics (MCRB) stock is held by retail investors.

Who owns the most shares of Seres Therapeutics (MCRB)?

Noubar Afeyan owns the most shares of Seres Therapeutics (MCRB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.